載入...
Liangxue Jiedu Formula Improves Psoriasis and Dyslipidemia Comorbidity via PI3K/Akt/mTOR Pathway
The pathological mechanism of psoriasis and dyslipidemia comorbidity is unclear, and there are few reports on therapy. By establishing an animal model of ApoE(−/−) mice induced by imiquimod (IMQ), we explored the effects of Liangxue Jiedu formula (LXJDF), a traditional Chinese herb medicine, on psor...
Na minha lista:
| 發表在: | Front Pharmacol |
|---|---|
| Main Authors: | , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Frontiers Media S.A.
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7982894/ https://ncbi.nlm.nih.gov/pubmed/33762935 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2021.591608 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|